1. Medtech Insight
  2. >>Policy & Regulation

News We’re Watching: Apple Watch Imports Blocked, Fresenius Recall, Groups Ask For Longer LDT Comment Period

 
• By Brian Bossetta, Hannah Daniel, and Elizabeth Orr

This week, the International Trade Commission ruled in favor of Masimo and blocked the import of some Apple Watches; Fresenius faced a recall; City of Hope announced a pancreatic cancer grant; and organizations asked for a longer comment period on the US FDA’s proposed rule on lab-developed tests.

Regulatory News We're Watching
• Source: Shutterstock

The International Trade Commission has upheld a preliminary decision that Apple Inc violated two of Masimo Inc’s pulse oximeter patents and has issued a limited exclusion order that will block the import of Apple Watches with the technology. It also issued a cease-and-desist order against the tech giant.

The 26 October decision was delayed from a 10 October deadline, which had originally been set for 17 July. (Also see "News We're Watching: FDA Announces Meetings On Ortho...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

FDLI: Clinical Labs Face Uncertainty After Texas Court’s LDT Ruling

 
• By Elizabeth Orr

A Texas court's decision against US FDA regulation of lab-developed tests (LDTs) has introduced new uncertainties for clinical labs. Industry stakeholders are now worried about potential future regulations while also managing existing compliance requirements. Recent conference discussions underscored the complexities of FDA oversight.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.